(Q38871606)

7 September 2017

Microglia activation and interaction with neuronal cells in a biochemical model of mevalonate kinase deficiency (English)

1 reference

7 September 2017

0 references

3

1 reference

7 September 2017

Giulio Kleiner

4

0 references

Annalisa Marcuzzi

object named as

Annalisa Marcuzzi

6

0 references

Elisa Piscianz

object named as

Elisa Piscianz

2

0 references

author name string

Paola Maura Tricarico

1

1 reference

PubMed ID

26003816

7 September 2017

Sergio Crovella

5

1 reference

7 September 2017

1 August 2015

1 reference

7 September 2017

1 reference

7 September 2017

20

1 reference

7 September 2017

1048-1055

1 reference

7 September 2017

8

1 reference

https://scigraph.springernature.com/pub.10.1007/s10495-015-1139-8

7 September 2017

0 references

cites work

Mevalonic aciduria--an inborn error of cholesterol and nonsterol isoprene biosynthesis

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1139-8

Allogeneic bone marrow transplantation in mevalonic aciduria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1139-8

Mevalonate kinase deficiencies: from mevalonic aciduria to hyperimmunoglobulinemia D syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1139-8

Cholesterol metabolism in neurons and astrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1139-8

Deletion of a single mevalonate kinase (Mvk) allele yields a murine model of hyper-IgD syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1139-8

Lovastatin-induced apoptosis is modulated by geranylgeraniol in a neuroblastoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1139-8

Lovastatin induces apoptosis through the mitochondrial pathway in an undifferentiated SH-SY5Y neuroblastoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1139-8

Defects in mitochondrial clearance predispose human monocytes to interleukin-1β hypersecretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1139-8

The lack of non-steroid isoprenoids causes oxidative stress in patients with mevalonic aciduria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1139-8

Clinical, genetic, and therapeutic diversity in 2 patients with severe mevalonate kinase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1139-8

Defect in mevalonate pathway induces pyroptosis in Raw 264.7 murine monocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1139-8

Microglial cell origin and phenotypes in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1139-8

Functions of microglia in the central nervous system--beyond the immune response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1139-8

Microglia: new roles for the synaptic stripper.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1139-8

The role of microglial activation in disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1139-8

21 January 2018

Physiology of microglia

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1139-8

Activated microglia contribute to neuronal apoptosis in Toxoplasmic encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1139-8

The P2Y12 receptor regulates microglial activation by extracellular nucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1139-8

Lovastatin dose-dependently potentiates the pro-inflammatory activity of lipopolysaccharide both in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1139-8

Microglial activation and TNFalpha production mediate altered CNS excitability following peripheral inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1139-8

Anakinra is safe and effective in controlling hyperimmunoglobulinaemia D syndrome-associated febrile crisis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1139-8

On-demand anakinra treatment is effective in mevalonate kinase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1139-8

Efficacy of interleukin-1-targeting drugs in mevalonate kinase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1139-8

Inhibition of IL-12/IL-23 signaling reduces Alzheimer's disease-like pathology and cognitive decline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1139-8

Neuroinflammatory cytokine signaling and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1139-8

Intrathecal granulocyte colony-stimulating factor modulate glial cell line-derived neurotrophic factor and vascular endothelial growth factor A expression in glial cells after experimental spinal cord ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1139-8

Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1139-8

Knockdown of MVK does not lead to changes in NALP3 expression or activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1139-8

10.1007/S10495-015-1139-8

21 January 2018

Identifiers

DOI

1 reference

7 September 2017

1 reference

PubMed ID

26003816